American Brain Tumor Association Names Jim Reilly Chair of the Board of Directors

The American Brain Tumor Association (ABTA), the first national advocacy organization committed to funding brain tumor research and providing education and information on all tumor types, announced today the appointment of Jim Reilly as Chair of the Board of Directors.

Founded in 1973, the ABTA’s mission is to advance the understanding and treatment of brain tumors with the goals of improving, extending, and ultimately saving the lives of those impacted by a brain tumor diagnosis. The ABTA represents the interests of the community of brain tumor scientists, patients, caregivers and donors by providing comprehensive resources to support the multi-faceted needs of brain tumor patients and caregivers, as well as funding critical research that works towards breakthroughs in the diagnosis, treatment, and care of brain tumors.

In his new role as Board Chair, Mr. Reilly will be responsible for leading the ABTA’s dedicated board members and providing strategic governance for the organization. He will work closely with Ralph DeVitto, president & chief executive officer, to enhance the ABTA’s reputation as the go-to source on brain tumor science and treatments.

Mr. Reilly has served on the ABTA board since 2014 and brings 20 years of experience in human resources and talent management in large corporate environments. Currently, Mr. Reilly is serving as the chief human resources officer for WinCo Foods, a $7 billion supermarket chain based in Boise, Idaho with 125 big box stores, 19,000 employee-owners, and locations in Arizona, California, Idaho, Nevada, Oklahoma, Oregon, Texas, Utah and Washington.

“Jim’s leadership skills and strategic drive make him the perfect choice to lead our organization into the next phase of its development as we work to increase our reach and impact,” said Brian Olson, ABTA past board chair. “We’re thrilled to have Jim devote his time and treasure to the ABTA.”

Founded in 1973, the American Brain Tumor Association is the first national patient advocacy organization committed to funding brain tumor research and providing support and education programs for all tumor types and ages. For more information, visit or call 800-886-ABTA (2282).